2012
DOI: 10.1179/2047773212y.0000000047
|View full text |Cite
|
Sign up to set email alerts
|

Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management

Abstract: Neurocysticercosis has been recognized as a major cause of secondary epilepsy worldwide. So far, most of the knowledge about the disease comes from Latin America and the Indian subcontinent. Unfortunately, in sub-Saharan Africa the condition was neglected for a long time, mainly owing to the lack of appropriate diagnostic tools. This review therefore focuses on the prevalence of neurocysticercosis in sub-Saharan Africa, the clinical picture with emphasis on epilepsy, as well as the diagnosis and treatment of n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
115
1
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 97 publications
(118 citation statements)
references
References 94 publications
1
115
1
1
Order By: Relevance
“…Patients mainly present with partial onset seizure with or without generalisation and have a high risk of seizure recurrence. Contrary to India, multiple lesions mainly of the intraparenchymal type seem to prevail in people with NCC from Latin America, sub-Saharan Africa and other Asian countries although scientific publications on NCC-related neuroimaging from sub-Saharan Africa and Asian countries other than India are rare [67,92,93].…”
Section: Staging Pathology and Clinical Characteristics Of Neurocystmentioning
confidence: 92%
See 2 more Smart Citations
“…Patients mainly present with partial onset seizure with or without generalisation and have a high risk of seizure recurrence. Contrary to India, multiple lesions mainly of the intraparenchymal type seem to prevail in people with NCC from Latin America, sub-Saharan Africa and other Asian countries although scientific publications on NCC-related neuroimaging from sub-Saharan Africa and Asian countries other than India are rare [67,92,93].…”
Section: Staging Pathology and Clinical Characteristics Of Neurocystmentioning
confidence: 92%
“…Such studies are desperately needed to evaluate the risk of symptomatic NCC with potentially ensuing death in many hundreds of thousands of people in sub-Saharan Africa. For more details on the calculation of how many people in sub-Saharan Africa would potentially be at risk of developing neurological side effects after mass drug administration of praziquantel and albendazole refer to Winkler [67].…”
Section: Prevalence Of Neurocysticercosis In Sub-saharan Africamentioning
confidence: 99%
See 1 more Smart Citation
“…Neurocysticercosis has been reported as the cause of around 20-50 % of secondary epilepsy in several countries in the world. (4) The incidence of taeniasis/cysticercosis is highest in Africa, Southeast Asia, Central and South America, and Europe. (3,5) In the Southeast Asian region research has been conducted on the prevalence of taeniasis and cysticercosis, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] Neurocysticercosis, an infection of the central nervous system, has been increasingly recognized as a lethal helminthic disease in both developing 1,5,6 and developed countries. [7][8][9] Among the Taeniae of humans, including T. solium, Taenia saginata, and Taenia asiatica, which cause taeniasis, [10][11][12][13] only T. solium causes cysticercosis in humans.…”
Section: Introductionmentioning
confidence: 99%